Superseded public profile

In clinical trials↗Metabolic↗

Superseded · version 1: Cagrilintide↗

Related names recorded in this version: AM833↗

A long-acting amylin analogue represented in ongoing ClinicalTrials.gov records.↗

This is preserved historical wording.
It is no longer the current profile. Read the canonical profile and its correction notice.

What this version reported

ClinicalTrials.gov lists a Novo Nordisk pediatric study as recruiting, updated July 17, 2026.↗

Organizations named in cited records:
  • Novo Nordisk A/S↗

Trial records: NCT07253285

Sources for this version

  1. 1
    Cagrilintide and CagriSema in Children and Adolescents With Excess Body Weight · record history version 5 · last update posted 2026-07-17 ↗

    ClinicalTrials.gov · Official source · Source checked July 22, 2026